Company Monitoring Page for Allergan

latest headlines for company on cafepharma

Allergan’s intravitreal implant wins approval in China
Drug Delivery Business News
Mon, 10/30/17 - 09:54 am
Tags:
Allergan, China, intravitreal implants, devices, Ozurdex, retinal vein occlusion
What to expect from the rest of pharma's earnings
BioPharma Dive
Mon, 10/30/17 - 09:52 am
Tags:
earnings, Pfizer, Allergan, Novo Nordisk, Sanofi, AstraZeneca
Allergan: Is Linzess 'Restasis 2.0'?
NY Shock Exchange
Mon, 10/23/17 - 09:42 am
Tags:
Allergan, Restasis, patents, Linzess, Ironwood Pharmaceuticals, Teva Pharmaceutical, IBS-C
Buzz: Will Brent Saunders split up Allergan if he loses the Restasis patent fight?
Endpoints
Sat, 10/21/17 - 09:44 pm
Tags:
Allergan, Brent Saunders, patents, Restasis
The 11 most innovative medical devices of 2017
Mass Device
Fri, 10/20/17 - 09:51 am
Tags:
devices, Abbott Labs, CardioMEMS, Allergan, Juvederm Vorbella XC, Boston Scientific, SpyGlass DS, WATCHMAN, BrainScope, BrainScope One, InSightec, Exablate Neuro, Integra LifeSciences, Omnigraft, JNJ, DePuy Synthes, Attune knee, Ethicon, Evarrest, Konig, Breast CT 1000, Biosense Webster, Thermocool SmartTouch SF Catheter
Allergan's stock-price struggles sure to trigger breakup questions: analyst
Fierce Pharma
Fri, 10/20/17 - 08:40 am
Tags:
Allergan
Court Finds Restasis Patents Invalid, Raises Concerns About Allergan, Mohawk Tribe Agreement
RAPS.org
Mon, 10/16/17 - 09:47 pm
Tags:
Allergan, patents, Restasis, Texas, Mylan Labs
'Sham' or legit? Texas judge set to weigh in on Allergan's tribal patent deal
Fierce Pharma
Mon, 10/16/17 - 12:53 pm
Tags:
Texas, Allergan, patents, Restasis, Mylan Labs
Allergan settles Restasis patent challenge after moving patents to Native American tribe
Drug Delivery Business News
Fri, 10/13/17 - 11:55 am
Tags:
Allergan, Restasis, patents, InnoPharma
Ten big lobbying groups turn their guns on Allergan’s controversial patent gambit
Endpoints
Wed, 10/11/17 - 11:22 am
Tags:
Allergan, patents, Restasis, lobbying
Allergan's Forest Labs to pay $4 million to settle discrimination charges by former sales reps
Reuters
Tue, 10/10/17 - 11:27 am
Tags:
Allergan, drug reps, gender discrimination
Allergan shows how you can destroy your rep and get mobbed by lawmakers in 4 easy steps
Endpoints
Fri, 10/6/17 - 09:44 am
Tags:
Allergan, patents, Restasis
3 Big Pharma Stocks Set to Succeed
Motley Fool
Thu, 10/5/17 - 09:36 am
Tags:
AbbVie, Humira, patents, Allergan, Botox, Celgene, Revlimid
Allergan moneymaker Botox grabs another cosmetic approval, this time in forehead lines
Fierce Pharma
Wed, 10/4/17 - 11:21 am
Tags:
Allergan, FDA, Botox
Allergan defends Restasis deal by calling for review of patent challenge process
Fierce Pharma
Tue, 10/3/17 - 11:59 am
Tags:
Allergan, Restasis, Pharma CEOs, patents, Brent Saunders
Allergan’s tribal treaty in Restasis patent fight triggers a Congressional dispute
Endpoints
Thu, 09/28/17 - 09:37 am
Tags:
Allergan, Restasis, patents, US Congress
Allergan: $2 Billion Share Buybacks Confirm Growth Is Dead
Seeking Alpha
Tue, 09/26/17 - 10:01 am
Tags:
Allergan, share repurchase
Allergan hit with FDA refusal to file letter
BioPharma Dive
Mon, 09/25/17 - 07:26 pm
Tags:
Allergan, FDA, refuse to file letters, Vraylar
Two years on, Allergan’s $1.7B NASH drug still looks weak — at best
Endpoints
Fri, 09/22/17 - 11:16 am
Tags:
Allergan, NASH, Novartis, Cenicriviroc
Apple Likes the Patent ‘Death Squad.’ Allergan Pays to Avoid It
Bloomberg
Wed, 09/20/17 - 09:14 am
Tags:
Allergan, Apple, patents, Restasis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.